메뉴 건너뛰기
International Journal of Nanomedicine
Volumn 7, Issue , 2012, Pages 5283-5286
Targeting nanomaterials: Future drugs for cancer chemotherapy
Author keywords

[No Author keywords available]
Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CHITOSAN; DOCETAXEL; DOXORUBICIN; NANOMATERIAL; NANOPARTICLE; SELENIUM NANOPARTICLE; STEARIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN;
EID: 84870374804     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S36970     Document Type: Letter
Times cited : (10)
References (8)
  • 1
    • 14644439267 scopus 로고    scopus 로고
    • Cancer nanotechnology: Opportunities and challenges
    • Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5(3):161-171.
    • (2005) Nat Rev Cancer , vol.5 , Issue.3 , pp. 161-171
    • Ferrari, M.1
  • 2
    • 84555178913 scopus 로고    scopus 로고
    • Treating metastatic cancer with nanotechnology
    • Schroeder A, Heller DA, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer. 2012;12(1):39-50.
    • (2012) Nat Rev Cancer , vol.12 , Issue.1 , pp. 39-50
    • Schroeder, A.1    Heller, D.A.2
  • 3
    • 84856667905 scopus 로고    scopus 로고
    • Impact of nanotechnology in cancer: Emphasis on nanochemoprevention
    • Siddiqui IA, Adhami VM, et al. Impact of nanotechnology in cancer: emphasis on nanochemoprevention. Int J Nanomedicine. 2012;7:591-605.
    • (2012) Int J Nanomedicine , vol.7 , pp. 591-605
    • Siddiqui, I.A.1    Adhami, V.M.2
  • 4
    • 79957971638 scopus 로고    scopus 로고
    • Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): Preparation, pharmacokinetics, tissue distribution and antitumor activity
    • Wang L, Liu Z, et al. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm. 2011;413(1-2):194-201.
    • (2011) Int J Pharm , vol.413 , Issue.1-2 , pp. 194-201
    • Wang, L.1    Liu, Z.2
  • 5
    • 84862325100 scopus 로고    scopus 로고
    • Nanomedicine: Towards development of patient-friendly drug-delivery systems for oncological applications
    • Ranganathan R, Madanmohan S, et al. Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications. Int J Nanomedicine. 2012;7:1043-1060.
    • (2012) Int J Nanomedicine , vol.7 , pp. 1043-1060
    • Ranganathan, R.1    Madanmohan, S.2
  • 6
    • 84870384664 scopus 로고    scopus 로고
    • Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
    • Wang L, Li M, et al. Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy. Int J Nanomedicine. 2012;7:3281-3294.
    • (2012) Int J Nanomedicine , vol.7 , pp. 3281-3294
    • Wang, L.1    Li, M.2
  • 7
    • 84860471928 scopus 로고    scopus 로고
    • Nanoparticle delivery systems for cancer therapy: Advances in clinical and preclinical research
    • Egusquiaguirre SP, Igartua M, et al. Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research. Clin Transl Oncol. 2012;14(2):83-93.
    • (2012) Clin Transl Oncol , vol.14 , Issue.2 , pp. 83-93
    • Egusquiaguirre, S.P.1    Igartua, M.2
  • 8
    • 33644593889 scopus 로고    scopus 로고
    • Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery
    • Khalil IA, Kogure K, et al. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev. 2006;58(1): 32-45.
    • (2006) Pharmacol Rev , vol.58 , Issue.1 , pp. 32-45
    • Khalil, I.A.1    Kogure, K.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.